Diaceutics (DXRX) Competitors GBX 160 -2.00 (-1.23%) As of 08:42 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock DXRX vs. YGEN, ABDX, VRCI, GENI, AGL, PRM, GDR, IDHC, DMTR, and LLAIShould you be buying Diaceutics stock or one of its competitors? The main competitors of Diaceutics include Yourgene Health (YGEN), Abingdon Health (ABDX), Verici Dx (VRCI), GENinCode (GENI), ANGLE (AGL), Proteome Sciences (PRM), genedrive (GDR), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), and LungLife AI (LLAI). These companies are all part of the "diagnostics & research" industry. Diaceutics vs. Its Competitors Yourgene Health Abingdon Health Verici Dx GENinCode ANGLE Proteome Sciences genedrive Integrated Diagnostics Deepmatter Group LungLife AI Yourgene Health (LON:YGEN) and Diaceutics (LON:DXRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment. Do insiders & institutionals hold more shares of YGEN or DXRX? 23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 32.2% of Diaceutics shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by company insiders. Comparatively, 26.3% of Diaceutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, YGEN or DXRX? Diaceutics has higher revenue and earnings than Yourgene Health. Diaceutics is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioYourgene Health£29.67M0.00-£8.17M-£0.01N/ADiaceutics£34.40M3.94-£2.84M-£0.02-8,888.89 Does the media prefer YGEN or DXRX? In the previous week, Diaceutics had 1 more articles in the media than Yourgene Health. MarketBeat recorded 1 mentions for Diaceutics and 0 mentions for Yourgene Health. Diaceutics' average media sentiment score of 1.11 beat Yourgene Health's score of 0.00 indicating that Diaceutics is being referred to more favorably in the news media. Company Overall Sentiment Yourgene Health Neutral Diaceutics Positive Is YGEN or DXRX more profitable? Diaceutics has a net margin of -10.90% compared to Yourgene Health's net margin of -27.55%. Diaceutics' return on equity of -7.15% beat Yourgene Health's return on equity.Company Net Margins Return on Equity Return on Assets Yourgene Health-27.55% -27.06% -6.71% Diaceutics -10.90%-7.15%-6.06% Do analysts rate YGEN or DXRX? Diaceutics has a consensus target price of GBX 175, suggesting a potential upside of 9.38%. Given Diaceutics' stronger consensus rating and higher probable upside, analysts plainly believe Diaceutics is more favorable than Yourgene Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yourgene Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Diaceutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, YGEN or DXRX? Yourgene Health has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Diaceutics has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. SummaryDiaceutics beats Yourgene Health on 11 of the 15 factors compared between the two stocks. Get Diaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DXRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXRX vs. The Competition Export to ExcelMetricDiaceuticsDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£135.38M£51.31M£6.08B£2.56BDividend YieldN/A3.87%5.73%5.32%P/E Ratio-8,888.890.9984.694,392.87Price / Sales3.94545.20596.0499,529.17Price / Cash3.1211.4237.8627.90Price / Book3.492.7912.288.16Net Income-£2.84M£334.07B£3.32B£5.89B7 Day Performance-1.23%0.12%1.30%-0.56%1 Month Performance10.73%-7.31%8.49%1.40%1 Year Performance20.30%-0.06%72.74%136.87% Diaceutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRXDiaceutics1.3576 of 5 starsGBX 160-1.2%GBX 175+9.4%+20.8%£135.38M£34.40M-8,888.89151Positive NewsYGENYourgene HealthN/AN/AN/AN/A£16.43M£29.67M-51.50253ABDXAbingdon HealthN/AGBX 5.89-1.9%N/A-30.6%£11.40M£6.82M-806.1684VRCIVerici DxN/AGBX 0.65-7.1%N/A-80.5%£9.84M£1.91M-22.4119Negative NewsGap DownGENIGENinCodeN/AGBX 3.28-8.9%N/A-24.3%£9.41M£2.91M-139.572,300Gap DownAGLANGLE1.9185 of 5 starsGBX 2.38+25.0%GBX 40+1,584.2%-77.5%£7.66M£2.62M-49.48650News CoverageGap DownHigh Trading VolumePRMProteome SciencesN/AGBX 1.91+3.5%N/A-32.2%£5.64M£4.53M-168.94240Gap UpGDRgenedriveN/AGBX 0.36+44.9%N/A-78.9%£3.64M£676K-16.4443High Trading VolumeIDHCIntegrated DiagnosticsN/AGBX 0.46-1.7%N/A+24.4%£2.67M£5.72B0.256,692Gap DownDMTRDeepmatter GroupN/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap DownLLAILungLife AIN/AGBX 3.50-17.6%N/A-63.6%£1.16M£33.87K-0.2815Gap DownHigh Trading Volume Related Companies and Tools Related Companies Yourgene Health Competitors Abingdon Health Competitors Verici Dx Competitors GENinCode Competitors ANGLE Competitors Proteome Sciences Competitors genedrive Competitors Integrated Diagnostics Competitors Deepmatter Group Competitors LungLife AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:DXRX) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
